Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | RNA | Homo sapiens | |||||||
GSM5835428 |
KYSE150 cells
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835429 |
KYSE150 cells (shRNA vector CAFs in the upper chamber)
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835430 |
KYSE150 cells (PAFR shRNA CAFs in the upper chamber)
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835431 |
KYSE150 cells (Stat3 shRNA CAFs in the upper chamber)
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835432 |
KYSE150 PAFR shRNA cells
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835433 |
KYSE150 PAFR shRNA cells (CAFs in the upper chamber)
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835434 |
KYSE150 Stat3 shRNA cells
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835435 |
KYSE150 Stat3 shRNA cells (CAFs in the upper chamber)
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835436 |
CAFs
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835437 |
CAFs (KYSE150 cells in the upper chamber)
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835438 |
PAFR shRNA CAFs (KYSE150 cells in the upper chamber)
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835439 |
PAFR shRNA CAFs
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835440 |
Stat3 shRNA CAFs (KYSE150 cells in the upper chamber)
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5835441 |
Stat3 shRNA CAFs
|
RNA | 1 | di zhao | Jan 25, 2025 | ||||
GSM5834291 |
Whole blood_Taxifolin_After_No1
|
RNA | 1 | Fumika SHINOZAKI | Jan 24, 2025 | ||||
GSM5834292 |
Whole blood_Taxifolin_After_No2
|
RNA | 1 | Fumika SHINOZAKI | Jan 24, 2025 | ||||
GSM5834293 |
Whole blood_Taxifolin_After_No3
|
RNA | 1 | Fumika SHINOZAKI | Jan 24, 2025 | ||||
GSM5834294 |
Whole blood_Taxifolin_After_No4
|
RNA | 1 | Fumika SHINOZAKI | Jan 24, 2025 | ||||
GSM5834295 |
Whole blood_Taxifolin_After_No5
|
RNA | 1 | Fumika SHINOZAKI | Jan 24, 2025 | ||||
GSM5834296 |
Whole blood_Taxifolin_After_No6
|
RNA | 1 | Fumika SHINOZAKI | Jan 24, 2025 |